JEMO-PHARM A/S: Financial statements 2013
CVR: 10216109
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
JEMO-PHARM A/S (CVR 10216109) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 11,842,000 and a net result of DKK 1,485,000 compared with DKK 2,050,709 the year before. That is an increase of 8.1% compared with the year before. Equity in the 2013 report amounted to DKK 9,778,000. The solvency ratio was 35.9%.
- Gross Profit
- DKK 11,842,000
- Profit/Loss
- DKK 1,485,000
- Equity
- DKK 9,778,000
- Total Assets
- DKK 27,228,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 11.8 mio. | 1.5 mio. | 9.8 mio. | - |
| 2012 | - | 11 mio. | 2.1 mio. | 8.3 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
JEMO-PHARM A/S has published its annual report for 2012. Gross profit came to DKK 10,956,649, and the net result was DKK 2,050,709.
About JEMO-PHARM A/S
JEMO-PHARM A/S is a Danish company of the type Aktieselskab based in Stege, founded in 1986. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named CMA TERADATA A/S and TERADATA A/S. The management consists of Mikael Andreas Mohr. The board consists of Svend Aage Dreist Hansen (chair), Henrik Winther Olsen and Mikael Andreas Mohr. The company is owned by THE WHOLE COMPANY A/S and MAM Invest ApS. The company has 31 employees (2026). In 2025, the company reported a gross profit of DKK 11,929,000 and a net result of DKK 30,000 compared with DKK -8,629,000 the year before. Equity in the 2025 report amounted to DKK 10,041,000.